tegafur has been researched along with Female Genital Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, Y | 1 |
| Sekiguchi, I | 1 |
| Suzuki, M | 1 |
| Aida, I | 1 |
| Tamada, T | 1 |
| Nishida, M | 1 |
| Ueda, T | 1 |
| Kamiwatari, M | 1 |
| Kosya, S | 1 |
| Yamamoto, S | 1 |
| Shiokawa, H | 1 |
| Yamada, E | 1 |
| Nagata, Y | 1 |
| Inoue, S | 1 |
| Shibata, S | 1 |
| Okumura, A | 1 |
| Tanaka, T | 1 |
| Onitsuka, Y | 1 |
| Yoshimura, T | 1 |
| Aiko, A | 1 |
| Ikuta, Y | 1 |
| Fukuma, K | 1 |
| Matsuura, K | 1 |
1 review available for tegafur and Female Genital Neoplasms
| Article | Year |
|---|---|
[Phase III study of gynecologic cancer in Japan].
Topics: Adjuvants, Immunologic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Drug Combina | 2002 |
3 other studies available for tegafur and Female Genital Neoplasms
| Article | Year |
|---|---|
[Responsiveness of gynecological malignancies to oral antitumor agents in subrenal capsule assay and individualization of oral adjuvant chemotherapy].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols | 1990 |
[A study on UFT concentration in tissues and serum of patients with malignant gynecologic tumors following oral administration].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Genital | 1987 |
[UFT concentration in serum and tissues of patients with gynecologic malignant tumors following oral administration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrium; Female; Genital Neoplasms, Female; Huma | 1985 |